These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 28551021)
1. Optimization of a micro-scale, high throughput process development tool and the demonstration of comparable process performance and product quality with biopharmaceutical manufacturing processes. Evans ST; Stewart KD; Afdahl C; Patel R; Newell KJ J Chromatogr A; 2017 Jul; 1506():73-81. PubMed ID: 28551021 [TBL] [Abstract][Full Text] [Related]
2. Optimization of a platform process operating space for a monoclonal antibody susceptible to reversible and irreversible aggregation using a solution stability screening approach. Man A; Luo H; Levitskaya SV; Macapagal N; Newell KJ J Chromatogr A; 2019 Jul; 1597():100-108. PubMed ID: 30922716 [TBL] [Abstract][Full Text] [Related]
3. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells. Legmann R; Schreyer HB; Combs RG; McCormick EL; Russo AP; Rodgers ST Biotechnol Bioeng; 2009 Dec; 104(6):1107-20. PubMed ID: 19623562 [TBL] [Abstract][Full Text] [Related]
4. Scale-down model qualification of ambr® 250 high-throughput mini-bioreactor system for two commercial-scale mAb processes. Manahan M; Nelson M; Cacciatore JJ; Weng J; Xu S; Pollard J Biotechnol Prog; 2019 Nov; 35(6):e2870. PubMed ID: 31207168 [TBL] [Abstract][Full Text] [Related]
5. Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study. Bareither R; Bargh N; Oakeshott R; Watts K; Pollard D Biotechnol Bioeng; 2013 Dec; 110(12):3126-38. PubMed ID: 23775295 [TBL] [Abstract][Full Text] [Related]
6. Large scale demonstration of a process analytical technology application in bioprocessing: use of on-line high performance liquid chromatography for making real time pooling decisions for process chromatography. Rathore AS; Parr L; Dermawan S; Lawson K; Lu Y Biotechnol Prog; 2010; 26(2):448-57. PubMed ID: 19927320 [TBL] [Abstract][Full Text] [Related]
7. High throughput chromatography strategies for potential use in the formal process characterization of a monoclonal antibody. Petroff MG; Bao H; Welsh JP; van Beuningen-de Vaan M; Pollard JM; Roush DJ; Kandula S; Machielsen P; Tugcu N; Linden TO Biotechnol Bioeng; 2016 Jun; 113(6):1273-83. PubMed ID: 26639315 [TBL] [Abstract][Full Text] [Related]
8. Development of a scale down cell culture model using multivariate analysis as a qualification tool. Tsang VL; Wang AX; Yusuf-Makagiansar H; Ryll T Biotechnol Prog; 2014; 30(1):152-60. PubMed ID: 24124180 [TBL] [Abstract][Full Text] [Related]
9. State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation. Marichal-Gallardo PA; Alvarez MM Biotechnol Prog; 2012 Jul; 28(4):899-916. PubMed ID: 22641473 [TBL] [Abstract][Full Text] [Related]
10. A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line. Kuczewski M; Schirmer E; Lain B; Zarbis-Papastoitsis G Biotechnol J; 2011 Jan; 6(1):56-65. PubMed ID: 21170980 [TBL] [Abstract][Full Text] [Related]
11. Application of high-throughput mini-bioreactor system for systematic scale-down modeling, process characterization, and control strategy development. Janakiraman V; Kwiatkowski C; Kshirsagar R; Ryll T; Huang YM Biotechnol Prog; 2015; 31(6):1623-32. PubMed ID: 26317495 [TBL] [Abstract][Full Text] [Related]
12. Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production. Steinebach F; Müller-Späth T; Morbidelli M Biotechnol J; 2016 Sep; 11(9):1126-41. PubMed ID: 27376629 [TBL] [Abstract][Full Text] [Related]
13. Aggregates in monoclonal antibody manufacturing processes. Vázquez-Rey M; Lang DA Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193 [TBL] [Abstract][Full Text] [Related]
15. Progression of continuous downstream processing of monoclonal antibodies: Current trends and challenges. Somasundaram B; Pleitt K; Shave E; Baker K; Lua LHL Biotechnol Bioeng; 2018 Dec; 115(12):2893-2907. PubMed ID: 30080940 [TBL] [Abstract][Full Text] [Related]
16. Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm. Arnold L; Lee K; Rucker-Pezzini J; Lee JH Biotechnol J; 2019 Feb; 14(2):e1800061. PubMed ID: 29729129 [TBL] [Abstract][Full Text] [Related]
17. Decisional tool to assess current and future process robustness in an antibody purification facility. Stonier A; Simaria AS; Smith M; Farid SS Biotechnol Prog; 2012 Jul; 28(4):1019-28. PubMed ID: 22641562 [TBL] [Abstract][Full Text] [Related]
18. A practical strategy for using miniature chromatography columns in a standardized high-throughput workflow for purification development of monoclonal antibodies. Welsh JP; Petroff MG; Rowicki P; Bao H; Linden T; Roush DJ; Pollard JM Biotechnol Prog; 2014; 30(3):626-35. PubMed ID: 24616450 [TBL] [Abstract][Full Text] [Related]
19. Development of an automated mid-scale parallel protein purification system for antibody purification and affinity chromatography. Zhang C; Long AM; Swalm B; Charest K; Wang Y; Hu J; Schulz C; Goetzinger W; Hall BE Protein Expr Purif; 2016 Dec; 128():29-35. PubMed ID: 27498022 [TBL] [Abstract][Full Text] [Related]
20. Creation of a versatile automated two-step purification system with increased throughput capacity for preclinical mAb material generation. Ransdell AS; Reed M; Herrington J; Cain P; Kelly RM Protein Expr Purif; 2023 Jul; 207():106269. PubMed ID: 37023994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]